WHO says remdesivir does not treat COVID-19, doctors should not administer it

1,011FollowersFollow

The World Health Organization on Thursday recommended against the use of remdesivir to treat COVID-19, after concluding that the antiviral drug made by Gilead Sciences INC. does not reduce deaths or recovery times.

The WHO said its panel of international experts who advise the agency on treatments based its recommendation on four international clinical trials that compares the effects of several drug treatments.

“The antiviral drug remdesivir is not suggested for patients admitted to hospital with covid-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the need for ventilation,” a WHO Guideline Development Group (GDG) panel of international experts in The British Medical Journal said on Thursday.

It added that “the recommendation is part of a living guideline, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide trustworthy guidance on the management of covid-19 and help doctors make better decisions with their patients.”

Living guidelines are useful in fast moving research areas like covid-19 because they allow researchers to update previously vetted and peer reviewed evidence summaries as new information becomes available.

Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19 and is increasingly used to treat patients in hospital. But its role in clinical practice has remained uncertain.

“Today’s recommendation is based on a new evidence review comparing the effects of several drug treatments for covid-19. It includes data from four international randomised trials involving over 7,000 patients hospitalised for covid-19,” the panel said.

It added: “After thoroughly reviewing this evidence, the WHO GDG expert panel, which includes experts from around the world including four patients who have had covid-19, concluded that remdesivir has no meaningful effect on mortality or on other important outcomes for patients, such as the need for mechanical ventilation or time to clinical improvement.

“The panel acknowledged that the certainty of evidence is low and said the evidence did not prove that remdesivir has no benefit; rather, there is no evidence based on currently available data that it does improve important patient outcomes.

“But given the remaining possibility of important harm, as well as the relatively high cost and resource implications associated with remdesivir (it must be given intravenously), they judged this to be an appropriate recommendation,” WHO Guideline Development Group said, adding that “They also support continued enrolment into trials evaluating remdesivir, especially to provide higher certainty of evidence for specific groups of patients.”

Last October, the US Food and Drug Administration formally approved remdesivir as the first drug to treat COVID-19.

The F.D.A. said the drug had been approved for adults and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) who require hospitalization for COVID-19.

Simon Ateba
Simon Ateba
Based in Washington, District of Columbia, United States of America, Simon leads a brilliant team of reporters, freelance journalists, analysts, researchers and contributors from around the world to run TODAY NEWS AFRICA as editor-in-chief. Simon Ateba's journalistic experience spans over 10 years and covers many beats, including business and investment, information technology, politics, diplomacy, human rights, science reporting and much more. Write him: simonateba@todaynewsafrica.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Now

U.S. calls for independent probe into massacres in Tigray region in Ethiopia

The United States government on Thursday called for an independent investigation following massacres in the Tigray region in Ethiopia.The United States said the investigation...

Biden announces foreign policy and national security team, including Blinken as Secretary of State, Mayorkas as Secretary of Homeland Security and Kerry as envoy on climate

U.S. President-elect Joe Biden on Monday announced key members of his foreign policy and national security team, including Antony Blinken as Secretary of State;...

Trump campaign files appeal after Judge called legal claim in Pennsylvania “Frankenstein’s Monster” before dismissing it

President Donald Trump’s legal team on Sunday filed an appeal to a federal judge’s ruling that dismissed his campaign's effort to block the certification...

President-elect Joe Biden’s national security and foreign policy team praised as experienced and historic choices

U.S. President-elect Joe Biden announced key members of his national security and foreign policy team on Monday, including Antony Blinken as Secretary of State;...

Linda Thomas-Greenfield: “America is back. Multilateralism is back. Diplomacy is back.”

Linda Thomas-Greenfield, who has been nominated by President-elect, Joseph R. Biden Jr., to serve as the United States Ambassador to the United Nations, on...

Ethiopian forces set to take Tigrayan capital, as many fear mass civilian deaths

The Ethiopian military said late on Friday that government forces were set to take control of Mekelle, the regional capital of Tigray, even as...

Sex-bombing the continent: Africa’s most popular nude dancer, Zodwa Wabantu, deported from Zambia

Zodwa Wabantu, Africa's most popular nude dancer, has been deported from Zambia where she was due to perform.The government believed her lewd performance in...

Joe Biden will need to strengthen ties with Africa, says Navy SEAL admiral McRaven

President-elect Joseph R. Biden Jr. will need to "play the long game" by strengthening ties with the rest of the world, including the continent...

Pennsylvania Supreme Court allows state to complete certification of Biden win

The Supreme Court in Pennsylvania on Saturday allowed the state to complete the certification of its presidential vote won by President-elect Joseph R. Biden...

Biden announces additional COVID-19 advisory board members

U.S. President-elect Joe Biden on Saturday announced new members of the Transition COVID-19 Advisory Board.The team of leading public health experts is helping...

Hundreds of thousands of civilians trapped as Ethiopian war planes bomb Mekelle, Tigray’s regional capital

Hundreds of thousands of civilians were trapped on Saturday in Mekelle, the capital of Ethiopia's northern Tigray region, which came under "heavy bombardment."Aid workers...

Trump wasted $3 million in Wisconsin recount only for Biden to gain 132 votes, President could have donated the money to food bank

President Donald Trump seems to have wasted $3 million for recounts in two counties in Wisconsin, with President-elect Joe Biden gaining more votes.The...

Ethiopian forces set to take Tigrayan capital, as many fear mass civilian deaths

The Ethiopian military said late on Friday that government forces were set to take control of Mekelle, the regional capital of Tigray, even as...

What African Union envoys discussed with Prime Minister Abiy Ahmed of Ethiopia over escalating conflict in Tigray

The African Union has released a communique detailing what its envoys discussed with Prime Minister Abiy Ahmed of Ethiopia over the raging conflict in...

Joe Biden will need to strengthen ties with Africa, says Navy SEAL admiral McRaven

President-elect Joseph R. Biden Jr. will need to "play the long game" by strengthening ties with the rest of the world, including the continent of Africa, William Harry McRaven, a retired United States Navy four-star admiral, said on Sunday.Speaking on "ABC This Week", Admiral McRaven, who last served as the ninth commander of the United States Special Operations Command from August 8, 2011, to August 28, 2014, under President Barack...
error: Alert: Content is protected !!
Share
Tweet
WhatsApp
Pin
Share